Genmab | GEN - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Almirall EUR 2.76B 472.53M 2025-12
Amarin USD 290M 51M 2025-12
Amgen USD 195.44B 5.55B 2026-06
argenx SE USD 57.63B 13.25B 2026-06
AstraZeneca USD 289.99B 11.26B 2026-06
Bayer EUR 47.56B 8.87B 2026-06
BioMarin Pharmaceutical USD 11.06B 196M 2026-06
Demant DKK 56.79B 10.78B 2026-06
Exelixis USD 13.54B 2.65B 2026-06
Fresenius Medical Care EUR 10.55B 766.96M 2026-06
Genmab DKK 17.1B 88.06B 2026-06
GlaxoSmithKline GBP 80.14B 3.66B 2026-06
GN Store Nord DKK 13.17B 2.05B 2026-06
GRIFOLS EUR 5.41B 181.49M 2026-06
Hikma Pharmaceutical USD 4.63B 1.42B 2025-12
Insmed USD 23.11B 12.19B 2026-06
Lakefront Biotherapeutics EUR 1.73B 2.64M 2026-06
Lonza CHF 39.68B 980.61M 2025-06
Merck EUR 18.98B 27.8B 2026-06
Novartis USD 240.59B 67.17B 2026-06
Regeneron Pharmaceuticals USD 65.37B 16.31B 2026-06
Roche Holding CHF 270B 3.66B 2026-06
Sanofi EUR 91.15B 9.12B 2026-06
UCB EUR 46.41B 13.94B 2025-12